103 related articles for article (PubMed ID: 1331413)
1. Characterization of the inhibitory effect of adrenocorticotropin/melanocyte-stimulating hormone-like peptides on the binding of dopamine receptor ligands to the dopamine D2 receptor in vitro.
Florijn WJ; De Boer T; Tonnaer JA; Versteeg DH
J Pharmacol Exp Ther; 1992 Nov; 263(2):787-92. PubMed ID: 1331413
[TBL] [Abstract][Full Text] [Related]
2. ACTH/MSH-like peptides inhibit the binding of dopaminergic ligands to the dopamine D2 receptor in vitro.
Florijn WJ; De Boer T; Tonnaer JA; Van Nispen JW; Versteeg DH
Eur J Pharmacol; 1991 May; 207(1):43-50. PubMed ID: 1680721
[TBL] [Abstract][Full Text] [Related]
3. Co-operativity in agonist binding at the D2 dopamine receptor: evidence from agonist dissociation kinetics.
Kara E; Lin H; Strange PG
J Neurochem; 2010 Mar; 112(6):1442-53. PubMed ID: 20050980
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the mechanism of agonist and inverse agonist action at D2 dopamine receptors.
Roberts DJ; Lin H; Strange PG
Biochem Pharmacol; 2004 May; 67(9):1657-65. PubMed ID: 15081865
[TBL] [Abstract][Full Text] [Related]
5. D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]-MNPA, [3H]-(+)-PHNO, and [3H]-raclopride.
Peng T; Zysk J; Dorff P; Elmore CS; Ström P; Malmquist J; Ding M; Tuke D; Werkheiser J; Widzowski D; Mrzljak L; Maier D
Synapse; 2010 Aug; 64(8):624-33. PubMed ID: 20340171
[TBL] [Abstract][Full Text] [Related]
6. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
Levant B; Grigoriadis DE; DeSouza EB
J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154
[TBL] [Abstract][Full Text] [Related]
7. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
Booth RG; Baldessarini RJ; Kula NS; Gao Y; Zong R; Neumeyer JL
Mol Pharmacol; 1990 Jul; 38(1):92-101. PubMed ID: 1973525
[TBL] [Abstract][Full Text] [Related]
8. Perinatal asphyxia induces long-term changes in dopamine D1, D2, and D3 receptor binding in the rat brain.
Chen Y; Hillefors-Berglund M; Herrera-Marschitz M; Bjelke B; Gross J; Andersson K; von Euler G
Exp Neurol; 1997 Jul; 146(1):74-80. PubMed ID: 9225740
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D2 receptors in the anterior pituitary: a single population without reciprocal antagonist/agonist states.
George SR; Watanabe M; Seeman P
J Neurochem; 1985 Apr; 44(4):1168-77. PubMed ID: 2579204
[TBL] [Abstract][Full Text] [Related]
10. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
Chatterjee TK; Scott CE; Vazquez DM; Bhatnagar RK
Mol Pharmacol; 1988 Apr; 33(4):402-13. PubMed ID: 3357484
[TBL] [Abstract][Full Text] [Related]
11. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.
Narendran R; Hwang DR; Slifstein M; Talbot PS; Erritzoe D; Huang Y; Cooper TB; Martinez D; Kegeles LS; Abi-Dargham A; Laruelle M
Synapse; 2004 Jun; 52(3):188-208. PubMed ID: 15065219
[TBL] [Abstract][Full Text] [Related]
12. Dopamine D2 receptors mapped in rat brain with [3H](+)PHNO.
Nobrega JN; Seeman P
Synapse; 1994 Jul; 17(3):167-72. PubMed ID: 7974199
[TBL] [Abstract][Full Text] [Related]
13. Agonist binding fraction of dopamine D2/3 receptors in rat brain: a quantitative autoradiographic study.
Minuzzi L; Cumming P
Neurochem Int; 2010; 56(6-7):747-52. PubMed ID: 20117160
[TBL] [Abstract][Full Text] [Related]
14. Interaction of L-prolyl-L-leucyl glycinamide with dopamine D2 receptor: evidence for modulation of agonist affinity states in bovine striatal membranes.
Srivastava LK; Bajwa SB; Johnson RL; Mishra RK
J Neurochem; 1988 Mar; 50(3):960-8. PubMed ID: 2892892
[TBL] [Abstract][Full Text] [Related]
15. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
Roseboom PH; Gnegy ME
Mol Pharmacol; 1989 Jan; 35(1):139-47. PubMed ID: 2563306
[TBL] [Abstract][Full Text] [Related]
16. Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents.
Sautel F; Griffon N; Sokoloff P; Schwartz JC; Launay C; Simon P; Costentin J; Schoenfelder A; Garrido F; Mann A
J Pharmacol Exp Ther; 1995 Dec; 275(3):1239-46. PubMed ID: 8531087
[TBL] [Abstract][Full Text] [Related]
17. Dopamine receptors labelled by PHNO.
Seeman P; Ulpian C; Larsen RD; Anderson PS
Synapse; 1993 Aug; 14(4):254-62. PubMed ID: 7902615
[TBL] [Abstract][Full Text] [Related]
18. Dopamine displaces [3H]domperidone from high-affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: Implications for human positron emission tomography.
Seeman P; Tallerico T; Ko F
Synapse; 2003 Sep; 49(4):209-15. PubMed ID: 12827639
[TBL] [Abstract][Full Text] [Related]
19. Effect of desipramine during infancy and preweanling on dorsal striatal dopamine D1 and D2 receptor binding in adolescence in the rat.
Hilakivi I; Rinne J; Marjamäki P
Pol J Pharmacol; 1999; 51(4):311-6. PubMed ID: 10540962
[TBL] [Abstract][Full Text] [Related]
20. N-(p-isothiocyanatophenethyl)spiperone, a selective and irreversible antagonist of D2 dopamine receptors in brain.
Xu SX; Hatada Y; Black LE; Creese I; Sibley DR
J Pharmacol Exp Ther; 1991 May; 257(2):608-15. PubMed ID: 1674530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
